Biofourmis vs Veeva Systems
Side-by-side comparison of AI visibility scores, market position, and capabilities
Biofourmis is a digital health unicorn ($1.3B valuation) offering AI-driven remote patient monitoring and hospital-at-home platforms; raised $320M+ and partners with 50+ global health systems.
About
Biofourmis is a digital health company that delivers AI-powered remote patient monitoring, hospital-at-home programs, and clinical trial support platforms. Founded in 2015 and headquartered in Boston, Biofourmis combines wearable biosensors with machine learning algorithms to continuously monitor patients outside traditional clinical settings. Its platform enables health systems to discharge patients earlier while maintaining clinical oversight, reducing readmission rates and lowering costs of care. The company partners with more than 50 global health systems, payers, and pharmaceutical companies.
Veeva Systems (VEEV) reported $2.7B revenue in FY2025, up 14% YoY. #1 cloud platform for life sciences. ~8,000 employees. HQ: Pleasanton, CA. Market cap ~$40B.
About
Veeva Systems Inc. is the leading cloud software provider for the global life sciences industry, headquartered in Pleasanton, California. Founded in 2007 by Peter Gassner (a former Salesforce executive) and Matt Wallach, Veeva built its platform on Salesforce and later developed its own Vault cloud infrastructure. The company became a public benefit corporation (PBC) in 2021. Veeva reported revenues of $2.7B in fiscal year 2025 (ending January 2025), up 14% year-over-year, with a market capitalization of approximately $40B.
Key Details
Capabilities & Ecosystem
Capabilities
Integrations
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.